Benzinga | Nov 12, 2020 04:13PM EST

Akero Therapeutics Q3 EPS $(0.63) Down From $(0.56) YoY

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.63) per share. This is a 12.5 percent decrease over losses of $(0.56) per share from the same period last year.